Evergreen Nephrology, a Nashville, TN-based company which specializes in value-based kidney care, raised $130M in funding.
The round was led by Rubicon Founders, Oak HC/FT and a group of existing investors, with the addition of K2 HealthVentures.
The company intends to improve clinical outcomes, streamline care delivery, and ease the administrative burden on nephrologists.
Led by CEO John Donlan, Evergreen Nephrology partners with nephrologists and payors to redefine kidney care for patients with chronic and end-stage kidney disease.
The company offers nephrologists support through analytical insight and tools, and a dedicated care team for their patients consisting of nurse care managers, care coordinators, social workers, dietitians, and pharmacists. This interdisciplinary model ensures that patients receive holistic and personalized care while enabling nephrologists to focus on their clinical expertise and leadership in managing kidney disease.
Operating across 24 states with a network of over 900 providers, it delivers personalized, value-based care designed to empower patients and improve outcomes.
